<?xml-stylesheet type='text/xsl' href='anzctrTransform.xsl'?>
<ANZCTR_Trial requestNumber="320816">
  <stage>Registered</stage>
  <submitdate>11/11/2009</submitdate>
  <approvaldate>23/11/2009</approvaldate>
  <actrnumber>ACTRN12609001014246</actrnumber>
  <trial_identification>
    <studytitle>Treatment of acute pain after shingles with vitamin D cream</studytitle>
    <scientifictitle>Treatment of acute herpes zoster neuralgia with high potency vitamin D cream</scientifictitle>
    <utrn />
    <trialacronym />
  </trial_identification>
  <conditions>
    <healthcondition>Acute herpes zoster (shingles)</healthcondition>
    <healthcondition>Herpes zoster</healthcondition>
    <conditioncode>
      <conditioncode1>Infection</conditioncode1>
      <conditioncode2>Studies of infection and infectious agents</conditioncode2>
    </conditioncode>
  </conditions>
  <interventions>
    <interventions>Use of a topical high potency vitamin D cream (20,000IU/g).
a. Dose 20,000IU 
b. Twice a day
c. Until pain resolves or for up to 4 weeks</interventions>
    <comparator>No control group</comparator>
    <control>Uncontrolled</control>
    <interventioncode>Treatment: drugs</interventioncode>
  </interventions>
  <outcomes>
    <primaryOutcome>
      <outcome>Relief of pain measured using a visual analogue scale</outcome>
      <timepoint>Days 1,7,14, 21 and 28 of treatment</timepoint>
    </primaryOutcome>
    <secondaryOutcome>
      <outcome>Nil</outcome>
      <timepoint>Nil</timepoint>
    </secondaryOutcome>
  </outcomes>
  <eligibility>
    <inclusivecriteria>Age 18-80
Adults with acute herpetic neuralgia
Able to provide informed consent</inclusivecriteria>
    <inclusiveminage>18</inclusiveminage>
    <inclusiveminagetype>Years</inclusiveminagetype>
    <inclusivemaxage>80</inclusivemaxage>
    <inclusivemaxagetype>Years</inclusivemaxagetype>
    <inclusivegender>Both males and females</inclusivegender>
    <healthyvolunteer>No</healthyvolunteer>
    <exclusivecriteria>Unable to apply vitamin D cream
Skin condition or skin allergy so unable to use cream
Unable to provide informed consent</exclusivecriteria>
  </eligibility>
  <trial_design>
    <studytype>Interventional</studytype>
    <purpose>Treatment</purpose>
    <allocation>Non-randomised trial</allocation>
    <concealment />
    <sequence />
    <masking />
    <assignment />
    <designfeatures />
    <endpoint />
    <statisticalmethods />
    <masking1 />
    <masking2 />
    <masking3 />
    <masking4 />
    <patientregistry />
    <followup />
    <followuptype />
    <purposeobs />
    <duration />
    <selection />
    <timing />
  </trial_design>
  <recruitment>
    <phase>Phase 1</phase>
    <anticipatedstartdate>1/01/2010</anticipatedstartdate>
    <actualstartdate />
    <anticipatedenddate />
    <actualenddate />
    <samplesize>10</samplesize>
    <actualsamplesize />
    <recruitmentstatus>Not yet recruiting</recruitmentstatus>
    <recruitmentcountry>,Outside</recruitmentcountry>
    <recruitmentstate />
    <countryoutsideaustralia>
      <country>New Zealand</country>
      <state />
    </countryoutsideaustralia>
  </recruitment>
  <sponsorship>
    <primarysponsortype>Other</primarysponsortype>
    <primarysponsorname>Jim Bartley</primarysponsorname>
    <primarysponsoraddress>10 Owens Rd.,
Epsom
Auckland, 1023</primarysponsoraddress>
    <primarysponsorcountry>New Zealand</primarysponsorcountry>
    <fundingsource>
      <fundingtype>Self funded/Unfunded</fundingtype>
      <fundingname>Jim Bartley</fundingname>
      <fundingaddress>10 Owens Rd.,
Epsom
Auckland, 1023</fundingaddress>
      <fundingcountry>New Zealand</fundingcountry>
    </fundingsource>
    <secondarysponsor>
      <sponsortype>None</sponsortype>
      <sponsorname />
      <sponsoraddress />
      <sponsorcountry />
    </secondarysponsor>
  </sponsorship>
  <ethicsAndSummary>
    <summary>Vitamin D is able to treat viral infections. As such a high potency vitamin D cream could also be useful in the treatment of the acute viral reactivation associated with acute herpes zoster.  

Inflammation of cells called glial and schwann cells which surround nerves in our nervous system are also known to have a major influence on pain.  Drugs that reduce inflammation in these cells are now being trialled in a number of pain conditions.  One drug/ natural supplement that offers particular promise is vitamin D.  Because post herpetic neuralgia responds to a number of topical medications, vitamin D is being trialled in a topical form. 

If a vitamin D cream was an effective treatment for acute post herpetic neuralgia this would be a major treatment advance as it  could provide a simple cost effective treatment option with minimal side effects.</summary>
    <trialwebsite />
    <publication>Bartley J. Post herpetic neuralgia, schwann cell activation and vitamin D.  Medical Hypotheses 2009 (accepted for publication)

Bartley J. Vitamin D, innate immunity and upper respiratory tract infection.  JLO 2009 (accepted for publication)</publication>
    <ethicsreview>Not yet submitted</ethicsreview>
    <publicnotes />
    <ethicscommitee>
      <ethicname />
      <ethicaddress />
      <ethicapprovaldate />
      <hrec>NTX/09/11/102</hrec>
      <ethicsubmitdate>10/11/2009</ethicsubmitdate>
      <ethiccountry />
    </ethicscommitee>
  </ethicsAndSummary>
  <attachment />
  <contacts>
    <contact>
      <title />
      <name>Jim Bartley</name>
      <address>10 Owens Rd.
Epsom
Auckland, 1023</address>
      <phone>6496310475</phone>
      <fax>6496310478</fax>
      <email>jbartley@ihug.co.nz</email>
      <country>New Zealand</country>
      <type>Scientific Queries</type>
    </contact>
    <contact>
      <title />
      <name>Jim Bartley</name>
      <address>10 Owens Rd.
Epsom
Auckland, 1023</address>
      <phone>6496310475</phone>
      <fax>6496310478</fax>
      <email>jbartley@ihug.co.nz</email>
      <country>New Zealand</country>
      <type>Public Queries</type>
    </contact>
    <contact>
      <title />
      <name />
      <address />
      <phone />
      <fax />
      <email />
      <country />
      <type>Updating Information</type>
    </contact>
    <contact>
      <title />
      <name />
      <address />
      <phone />
      <fax />
      <email />
      <country />
      <type>Principal Investigator</type>
    </contact>
  </contacts>
</ANZCTR_Trial>